pharmacometrics in phase 1: first in human and dose selection for phase 2
Published 3 years ago • 1K plays • Length 28:51Download video MP4
Download video MP3
Similar videos
-
27:42
pharmacometrics phase 2 proof-of-concept dose selection phase 3/marketing
-
7:43
introduction to fih/phase 1 track
-
20:56
pharmacometrics in phase 3 – data integration and analysis to support dose and labeling for the nda
-
4:56
introduction to phase ii track with joel owen
-
1:09
fully power your first-in-human predictions
-
7:58
drug calculations made ridiculously easy
-
2:31:56
modeling and simulation to select oncology dosages - session 3
-
1:02:34
the application of artificial intelligence/machine learning in drug development and regulation
-
24:42
clinical track: a physiologically pharmacokinetic model based approach for predicting dose of...
-
5:21
(review) first-in-human studies - pmda-atc learning videos
-
4:38
tryptamine therapeutics completes phase 1b of iv-infused psilocin trial
-
25:18
pharmacometrics post approval fulfillment of requirements label extension and life-cycle management
-
28:57
pre clinical track: ophthalmic clinical pharmacokinetic/pharmacodynamic prediction using pbpk model
-
58:50
animal scale up and first-in-human studies with dr. jerry collins
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development
-
4:42
introduction to phase iii track with beth ludwig
-
1:03:33
pharmacometrics symposium: applied meta-analysis in drug development
-
38:52
introduction to pharmacology | pharmacokinetics and pharmacodynamics basics
-
0:54
gastroplus® workshop: physiologically based pharmacokinetic modeling for fih predictions
-
54:05
using pk data for better in vitro and in vivo drug dosing and study design
-
14:09
population pharmacokinetic evaluation & missed-dose simulations eslicarbazepine acetate monotherapy